| Business

Become a contributor

Bookmark Econotimes

| Business

Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement

Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny

BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer

Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market

Ireland’s Data Protection Commission Launches GDPR Investigation Into X’s AI Chatbot Grok

India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi

Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged

Santos Wins Court Case Over Net Zero and Sustainability Claims

Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims

Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings

BHP Group Half-Year Profit Surges as Copper Overtakes Iron Ore on AI-Driven Demand

Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal

Anderson Cooper to Exit CBS News’ 60 Minutes After Nearly 20 Years

Reese’s Peanut Butter Cup Recipe Debate: Hershey Responds as Cocoa Prices Shift

Yotta to Build $2 Billion AI Data Centre Hub in India with Nvidia Blackwell Ultra Chips

European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA

YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails

©Econometrics LLC . All Rights Reserved.

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 2018

Tuesday, May 1, 2018 8:30 PM UTC

BUENA, N.J., May 01, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43^rd Annual Health Care Conference. The Conference is taking place May 8-9, 2018 at the Intercontinental Hotel, Boston.

Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Tuesday, May 8^th at 12:50 p.m. ET.

The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com. A replay will be available for 30 days.

About Teligent, Inc.

Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.

Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA

Zelenskiy Says Trump Pressuring Ukraine as Donbas Peace Talks Intensify

Xi Jinping Highlights People-to-People Ties as U.S.-China Relations Show Signs of Stabilization

Cambodia’s Hun Manet Urges Thailand to Resolve Border Dispute Amid Fragile Ceasefire

Yotta to Build $2 Billion AI Data Centre Hub in India with Nvidia Blackwell Ultra Chips

MicroStrategy Rebrands to Strategy, Scoops 2,486 BTC for $168M Amid ETF Bleed – Dip-Buying Empire Grows

Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South

Christine Lagarde Reportedly Set to Exit ECB Before End of Term

U.S. Official Alleges China Conducted Underground Nuclear Test at Lop Nor in 2020

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 2018

Editor's Picks

Welcome to EconoTimes